In vitro susceptibility of clinical Clostridioides difficile isolates in Israel to metronidazole, vancomycin, fidaxomicin, ridinilazole and ibezapolstat. - Schwartz O; Azrad M; Peretz A (BMC gastroenterology, 2025)